Abstract：【Objective】To explore the application value of the combined detection of serum human epididymis protein (HE4), carbohydrate antigen 125 (CA125) and CA199 in the diagnosis of gynecologic malignant tumors. 【Methods】Forty-two patients with gynecologic malignant tumors (group A) and 42 patients with gynecologic benign tumors (group B) were selected as study subjects. All cases underwent detection of HE4, CA125 and CA199. The positive rates of the three markers and ROC were compared. 【Results】The expression levels of HE4, CA125 and CA199 individually and in combination in group A were significantly higher than those in group B (P<0.05)。The positive rate, AUC under ROC curve, accuracy, specificity and sensitivity for the detection of the combination of markers in group A were higher than those of CA125 and CA199 alone (P<0.05), but those parameters did not show significant difference compared to those of HE4 alone (P>0.05 ). However, the sensitivity of the combined detection was significantly higher than that of HE4 alone (P<0.05).【Conclusion】The value of HE4 in diagnosing gynecologic malignant tumors is higher than CA125 and CA199 alone. The combined diagnosis of the three markers can further improve the differential diagnosis rate.
陈蓉;彭必江. 血清人附睾蛋白、CA125、CA199联合检测诊断妇科恶性肿瘤的价值[J]. 医学临床研究, 2017, 34(2): 321-323.
CHEN Rong; PENG Bi-jiang. Application of Combined Detection of Serum Human Epididymis Protein E4, CA125, and CA199 in the Diagnosis of Gynecologic Malignant Tumors. JOURNAL OF CLINICAL RESEARCH, 2017, 34(2): 321-323.
[1] 白朝怡,王颖梅,滕飞,等.血清人附睾分泌蛋白E4及CA125联合检测对子宫内膜癌淋巴结转移的预测价值[J].中华妇产科杂志,2014,49(7):543-546. [2] Zhang Z,Chen HX,Xiao-Xia XU.The values of the combined detection of serum human epididymis protein E4, CA125 and CA199 in diagnosis of endometrial cancer[J].J Pract Med,2016. 10(1):35-37 [3] 肖超强.常见妇科肿瘤血清中糖蛋白标志物的筛选分析[D].安徽医科大学,2014. [4] 孙洁, 杨聪慧, 朱一堂.CA125联合CA199检测在妇科肿瘤诊断中的应用[J].中国肿瘤临床与康复, 2016,23(3):278-280. [5] 张智,陈红霞,徐晓霞,等.血清人附睾蛋白E4、CA125、CA199联合诊断子宫内膜癌的价值[J].实用医学杂志,2016,32(7):1108-1111. [6] Menon U,Talaat A,Rosenthal AN,et al.Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening[J].BJOG,2014,107(19):165-169. [7] 王素英.血清肿瘤标志物CA125、CA153、CA199及癌胚抗原联合检测在卵巢癌早期诊断中的临床意义[J].国际医药卫生导报,2015,21(17):2620-2621. [8] 涂晓波,徐冬梅.人附睾蛋白4与糖类抗原CA125、CA199联合测定对卵巢癌的诊断价值[J].中国卫生检验杂志,2014,24(1):90-91. [9] 薛玉坤.人附睾蛋白4及CA125检测对卵巢癌的诊断价值[J].医学临床研究,2014,31(10):2025-2026,2027.
2017, Vol. 34 
